• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

FDA Recalls Zantac

April 3, 2020

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Dr. Garrett encourages otolaryngologists to check out the FDA announcement and understand why the drug was taken off the market.

You Might Also Like

  • FDA Works to Increase Consumer Access to Hearing Aids
  • FDA Warns about Cross-Contamination Risk From 24-Hour Multi-Patient Use Endoscope Connectors
  • FDA Warning Slows, but Does Not Stop, Codeine Prescribing in Children after Tonsillectomy
  • FDA Requires Naloxone Discussion to Be Part of Opioid Labeling, Prescribing

“We should all be more curious when things like this are announced, because our patients are going to want to know, and if we don’t have the right information, we’re going to be guilty of giving them the wrong information,” she said.

Pages: 1 2 | Single Page

Filed Under: News, Online Exclusives Tagged With: FDA

You Might Also Like:

  • FDA Works to Increase Consumer Access to Hearing Aids
  • FDA Warns about Cross-Contamination Risk From 24-Hour Multi-Patient Use Endoscope Connectors
  • FDA Warning Slows, but Does Not Stop, Codeine Prescribing in Children after Tonsillectomy
  • FDA Requires Naloxone Discussion to Be Part of Opioid Labeling, Prescribing

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

What do you think about ankyloglossia?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • A Letter to My Younger Self: Making Deliberate Changes Can Help Improve the Sense of Belonging
  • ENTtoday Welcomes Resident Editorial Board Members
  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Keeping Watch for Skin Cancers on the Head and Neck

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • “Custom-Based Medicine,” Welcome to Reality!
    • Exploring Controversies and Clinical Practices Surrounding Ankyloglossia
    • Otolaryngologists Outside the Office
    • The Power of AI in Otolaryngology
    • Secondary Contouring for the Butterfly Graft: Improving Form and Preserving Function

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939